Association between cytotoxic T-lymphocyte associated protein 4 gene +49 A/G polymorphism and chronic infection with hepatitis B virus: A meta-analysis

Journal of International Medical Research

Volumn 41, Issue 3, 2013, Pages 559-567

  Xu, Hangdi ^a   Zhao, Mingfei ^b   He, Jiliang ^c   Chen, Zhi ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chronic hepatitis B infection; CTLA4; cytotoxic T lymphocyte associated protein 4; HBV; meta analysis; single nucleotide polymorphism

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ARTICLE; CTLA4 GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; NONHUMAN; RISK ASSESSMENT; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; VIRAL CLEARANCE;

CHRONIC HEPATITIS B INFECTION; CTLA4; CYTOTOXIC T-LYMPHOCYTE ASSOCIATED PROTEIN 4; HBV; META-ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; CTLA-4 ANTIGEN; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; T-LYMPHOCYTES, CYTOTOXIC; VIRUS REPLICATION;

EID: 84887347154     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513483387     Document Type: Article

References (26)

1. Fattovich G.Natural history and prognosis of hepatitis B.Semin Liver Dis. 2003;23:47-58.
2. Thio CL,Mosbruger TL,Kaslow RA,et al.Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.J Virol. 2004;78:11258-11262.
3. Mohammad Alizadeh AH,Hajilooi M,Ranjbar M,et al.Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to chronic hepatitis B.World J Gastroenterol. 2006;12:630-635.
4. Gu X,Qi P,Zhou F,et al.+49G > A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population.Hum Immunol. 2010;71:83-87.
5. Sojka DK,Hughson A,Fowell DJ.CTLA-4 is required by CD4+CD25+ Treg to control CD4+T-cell lymphopenia-induced proliferation.Eur J Immunol. 2009;39:1544-1551.
6. Masteller EL,Chuang E,Mullen AC,et al.Structural analysis of CTLA-4 function in vivo.J Immunol. 2000;164:5319-5327.
7. Kirman J,McCoy K,Hook S,et al.CTLA-4 blockade enhances the immune response induced by mycobacterial infection but does not lead to increased protection.Infect Immun. 1999;67:3786-3792.
8. Pedicord VA,Montalvo W,Leiner IM,et al.Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance.Proc Natl Acad Sci USA. 2011;108:266-271.
9. Karandikar NJ,Vanderlugt CL,Walunas TL,et al.CTLA-4: a negative regulator of autoimmune disease.J Exp Med. 1996;184:783-788.
10. Kavvoura FK,Ioannidis JP.CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE Review and meta-analysis.Am J Epidemiol. 2005;162:3-16.
11. Zhao SX,Pan CM,Cao HM,et al.Association of the CTLA4 gene with Graves' disease in the Chinese Han population.PLoS One. 2010;5:e9821-e9821.
12. Lee YH,Harley JB,Nath SK.CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): A meta-analysis.Hum Genet. 2005;116:361-367.
13. Balic I,Angel B,Codner E,et al.Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children.Hum Immunol. 2009;70:116-120.
14. Hou R,Cao B,Chen Z,et al.Association of cytotoxic T lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer.Mol Biol Rep. 2010;37:515-520.
15. Yang M,Sun T,Zhou Y,et al.The functional cytotoxic T lymphocyte-associated Protein 4 49G-to-A genetic variant and risk of pancreatic cancer.Cancer. 2012;118:4681-4686.
16. Zhang G,Han Q,Duan S,et al.PDCD1 polymorphism amplifies the predisposing effect conferred by CTLA4 polymorphism in chronic hepatitis Bvirus infection.Hum Immunol. 2012;73:421-425.
17. Zhang YF,Xie JX,Gao YF.Study on association between the single nucleotide polymorphism of cytotoxic T lymphocyte associated agent 4 gene exon 1 region and outcome of patients with hepatitis B infection.J Clin Hepatol. 2007;11:297-299.
18. Chen DQ,Zeng Y,Zhou J,et al.Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population.J Med Virol. 2010;82:371-378.
19. Liu G,Lu GX.Association of CTLA4 gene +49G/A polymorphism with HBV infection and HBV-related hepatocellular carcinoma in Hunan Han population.Nan Fang Yi Ke Da Xue Xue Bao. 2010;30:1838-1840.
20. Hodi FS.Cytotoxic T-lymphocyte-associated antigen-4.Clin Cancer Res. 2007;13:5238-5242.
21. Carreno BM,Bennett F,Chau TA,et al.CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.J Immunol. 2000;165:1352-1356.
22. Belkaid Y,Piccirillo CA,Mendez S,et al.CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.Nature. 2002;420:502-507.
23. Yung E,Cheng PS,Fok TF,et al.CTLA-4 gene A-G polymorphism and childhood Graves' disease.Clin Endocrinol (Oxf). 2002;56:649-653.
24. Mäurer M,Loserth S,Kolb-Mäurer A,et al.A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation.Immunogenetics. 2002;54:1-8.
25. Ueda H,Howson JMM,Esposito L,et al.Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.Nature. 2003;423:506-511.
26. Gerold KD,Zheng P,Rainbow DB,et al.The soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell function.Diabetes. 2011;60:1955-1963.